PMID- 10318796 OWN - NLM STAT- MEDLINE DCOM- 19990617 LR - 20210209 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 274 IP - 20 DP - 1999 May 14 TI - Tumor necrosis factor-alpha-induced proliferation of human Mo7e leukemic cells occurs via activation of nuclear factor kappaB transcription factor. PG - 13877-85 AB - Tumor necrosis factor-alpha (TNF-alpha) stimulates proliferation of Mo7e, CMK, HU-3, and M-MOK human leukemic cell lines. We report here the signal transduction pathway involved in TNF-alpha-induced Mo7e cell proliferation. Mo7e cells spontaneously die in the absence of growth factors, but treating the cells with interleukin (IL)-3, IL-6, thrombopoietin, granulocyte/macrophage colony-stimulating factor, or TNF-alpha promotes their survival and proliferation. Although most of these factors activate MAP kinase and Jun NH2-terminal kinase/signal transducer and activators of transcription signaling pathways, TNF-alpha fails to activate either pathway. When Mo7e cells were treated with TNF-alpha, nuclear factor kappaB (NF-kappaB) was activated transiently. The activated NF-kappaB consisted of heterodimers of p65 and p50 subunits. The degradation of IkappaBalpha coincided with activation of NF-kappaB in TNF-alpha-treated cells. To investigate the role of activated NF-kappaB in TNF-alpha-induced Mo7e proliferation, a cell-permeable peptide (SN50) carrying the nuclear localization sequence of p50 NF-kappaB was used to block nuclear translocation of activated NF-kappaB. Pretreating Mo7e cells with SN50 blocked TNF-alpha-induced nuclear translocation of NF-kappaB and inhibited TNF-alpha-induced Mo7e cell survival and proliferation. A mutant SN50 peptide did not affect TNF-alpha-induced Mo7e cell growth. SN50 had no effects on IL-3- or granulocyte/macrophage colony-stimulating factor-induced Mo7e cell proliferation. The results indicate that activation of NF-kappaB is involved in TNF-alpha-induced Mo7e cell survival and proliferation. FAU - Liu, R Y AU - Liu RY AD - Division of Medical Oncology and Hematology, and Departments of Biochemistry/Molecular Biology and Anatomy, University of South Florida and the H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA. liur@moffitt.usf.edu FAU - Fan, C AU - Fan C FAU - Olashaw, N E AU - Olashaw NE FAU - Wang, X AU - Wang X FAU - Zuckerman, K S AU - Zuckerman KS LA - eng GR - CA56072/CA/NCI NIH HHS/United States GR - P30 CA76292/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (DNA-Binding Proteins) RN - 0 (Interleukin-3) RN - 0 (Milk Proteins) RN - 0 (NF-kappa B) RN - 0 (Peptides) RN - 0 (SN50 peptide) RN - 0 (STAT5 Transcription Factor) RN - 0 (Trans-Activators) RN - 0 (Tumor Necrosis Factor-alpha) RN - 83869-56-1 (Granulocyte-Macrophage Colony-Stimulating Factor) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinases) RN - EC 2.7.11.24 (JNK Mitogen-Activated Protein Kinases) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) SB - IM MH - Calcium-Calmodulin-Dependent Protein Kinases/metabolism MH - Cell Division MH - Cell Nucleus/metabolism MH - DNA-Binding Proteins/metabolism MH - Granulocyte-Macrophage Colony-Stimulating Factor/metabolism MH - Humans MH - Interleukin-3/metabolism MH - JNK Mitogen-Activated Protein Kinases MH - *Milk Proteins MH - *Mitogen-Activated Protein Kinases MH - NF-kappa B/antagonists & inhibitors/*metabolism MH - Peptides/metabolism MH - STAT5 Transcription Factor MH - Trans-Activators/metabolism MH - Tumor Cells, Cultured MH - Tumor Necrosis Factor-alpha/*pharmacology EDAT- 1999/05/13 00:00 MHDA- 1999/05/13 00:01 CRDT- 1999/05/13 00:00 PHST- 1999/05/13 00:00 [pubmed] PHST- 1999/05/13 00:01 [medline] PHST- 1999/05/13 00:00 [entrez] AID - S0021-9258(19)73248-7 [pii] AID - 10.1074/jbc.274.20.13877 [doi] PST - ppublish SO - J Biol Chem. 1999 May 14;274(20):13877-85. doi: 10.1074/jbc.274.20.13877.